Authors
Makhmudov R.Sh.
Tashkent State Medical University, Tashkent, Republic of Uzbekistan
Abstract
Purpose. To perform a clinical and functional evaluation of ocular tone disturbances and their consequences in patients with thyroid eye disease (TED), with an emphasis on determining the role of structural changes in Schlemm’s canal in the development of ocular hypertension.
Materials and Methods. Ninety-two patients (150 eyes) were examined and divided into four groups: TED with ocular hypertension, TED without ocular hypertension, primary open‑angle glaucoma, and healthy controls. Comprehensive ophthalmological assessment included visual acuity testing, tonometry, tonography, perimetry, optical coherence tomography (OCT) of the anterior segment and optic nerve head, as well as morphometric analysis of Schlemm’s canal. The NOSPECS and CAS scales were used to assess disease activity.
Results and Discussion. Patients with TED and ocular hypertension demonstrated significantly more severe disease manifestations according to the NOSPECS scale, a decreased outflow coefficient (0,12±0,02 mm³/min/mm Hg), elevated intraocular pressure and ocular rigidity coefficient, and morphological narrowing of Schlemm’s canal. These parameters correlated with retinal nerve fiber layer (RNFL) thickness and the severity of visual field defects, closely resembling the ocular hydrodynamic profile of primary open‑angle glaucoma.
Conclusion. Ocular tone disturbances in thyroid eye disease are associated with morphofunctional changes of the ocular drainage system and require early diagnosis using OCT and tonography for timely detection of ocular hypertension and prevention of glaucomatous complications.
Keywords: thyroid eye disease, ocular hypertension, intraocular pressure, Schlemm’s canal, optical coherence tomography.
References
1. Betzler BK, Young SM, Sundar G. Intraocular Pressure and Glaucoma in Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2022 May-Jun 01;38(3):219-225. doi: 10.1097/IOP.0000000000002049.
2. Ghenciu LA, Șișu AM, Stoicescu ER, Dănilă AI, Iacob R, Săndesc MA, Hațegan OA. Thyroid Eye Disease and Glaucoma: A Cross-Sectional Study Comparing Clinical Characteristics and Disease Severity. Medicina (Kaunas). 2024 Sep 1;60(9):1430. doi: 10.3390/medicina60091430.
3. Bagatin F, Prpić A, Škunca Herman J, Zrinšćak O, Iveković R, Vatavuk Z. Correlation between Structural and Functional Changes in Patients with Raised Intraocular Pressure Due to Graves’ Orbitopathy. Diagnostics (Basel). 2024 Mar 20;14(6):649. doi: 10.3390/diagnostics14060649.
4. Gautam Adhikari P, Shrestha GB. Evaluation of Intraocular Pressure in Thyroid-associated Orbitopathy. J Nepal Health Res Counc. 2022 Mar 13;19(4):824-829. doi: 10.33314/jnhrc.v19i04.3963.
5. Adetunji MO, Nguyen BJ, McGeehan B, Tamhankar MA, Briceño CA. Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy. Taiwan J Ophthalmol. 2022 Aug 1;12(3):325-329. doi: 10.4103/tjo.tjo_30_22.
6. Cockerham KP, Pal C, Jani B, Wolter A, Kennerdell JS. The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology. 1997 Jun;104(6):914-7. doi: 10.1016/s0161-6420(97)30207-3.
7. Currie ZI, Lewis S, Clearkin LG. Dysthyroid eye disease masquerading as glaucoma. Ophthalmic Physiol Opt. 1991 Apr;11(2):176-9. doi: 10.1111/j.1475-1313.1991.tb00218.x.
8. Wang S, Liu Y, Zheng G. Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017 Oct 25;12(10):e0186634. doi: 10.1371/journal.pone.0186634.
9. Muñoz-Negrete FJ, Rebolleda G, Almodóvar F, Díaz B, Varela C. Hypothyroidism and primary open-angle glaucoma. Ophthalmologica. 2000 Sep-Oct;214(5):347-9. doi: 10.1159/000027518.
10. Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, Leung AM, Mombaerts I, Salvi M, Stan MN. Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association. Eur Thyroid J. 2022 Dec 8;11(6):e220189. doi: 10.1530/ETJ-22-0189.
11. Scarabosio A, Surico PL, Singh RB, Tereshenko V, Musa M, D’Esposito F, Russo A, Longo A, Gagliano C, Agosti E, Jhanji E, Zeppieri M. Thyroid Eye Disease: Advancements in Orbital and Ocular Pathology Management. J Pers Med. 2024 Jul 22;14(7):776. doi: 10.3390/jpm14070776.
